AAO 2024: New gene therapy shows promise for treatment of …
2024年10月20日 · New research unveiled today at the 128th annual meeting of the American Academy of Ophthalmology in Chicago reveals that a novel gene therapy may improve vision in individuals with severe vision loss due to retinitis pigmentosa, a progressive inherited retinal disease for which no cure exists.
Ophthalmology Times - Ophthalmology news, articles, and events
In an interview with Ophthalmology Times, clinical trial investigator Zaina Al-Mohtaseb MD, noted the CLARA Phase 1/2 trial demonstrated the safety, efficacy, and simplicity of corneal endothelial cell injection therapy with a rho kinase inhibitor, offering a less invasive alternative to traditional corneal transplantation for treating corneal edema.
Johnson & Johnson launches TECNIS Odyssey IOL in US
2024年10月1日 · Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.. The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS platform from Johnson & Johnson, which according to the company provides two times better contrast in low lighting than PanOptix. 1 Peter Menziuso, company group chairman, Vision, Johnson & Johnson ...
AAO 2024: Livionex reports positive end-of-phase 2 meeting with …
2024年10月18日 · According to the company, there are no FDA-approved pharmacological therapies for age-related cataracts. Its C-KAD eye drop, improves vision in patients with early-to-moderate cataracts, by penetrating the eye to reduce lens clouding, the main cause for cataracts.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
2023年8月8日 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a …
Study suggests potential link between semaglutide and risk of non ...
2024年7月9日 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 …
The top 10 takeaways from AAO 2024 - ophthalmologytimes.com
2024年10月23日 · At the 2024 American Academy of Ophthalmology (AAO) meeting, held October 18 to 21 in Chicago, Illinois, ophthalmologists and researchers from around the world convened to share groundbreaking insights on the latest advancements in eye care.
AAO 2024: Gildeuretinol and Stargardt disease: The TEASE program
2024年10月20日 · Christine Kay, MD sat down to discuss her presentation on gildeuretinol and its slowing of progression of Stargardt disease, studied in the TEASE program at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
Intense pulsed light for treatment of dry eye disease
2024年10月31日 · Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic's campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX. The team reviewed demographics, ocular histories, Standard Patient Evaluation of Eye Dryness 2 symptom survey scores, slit-lamp examinations and meibomian gland evaluations at baseline and at each visit before IPL/MGX treatments.
Physicians sort out pros and cons of several new IOLs on the market
2021年11月12日 · Monofocal IOLs The monofocal category was expanded recently with 2 novel aspheric hydrophobic acrylic lenses—the TECNIS Eyhance (ICB00, Johnson + Johnson Vision) and the Clareon (Alcon). The Eyhance IOL has extended depth of focus (EDoF)-like qualities through the design of the central 1 mm of its optic. However, the Eyhance was not approved as an EDoF lens and surgeons cannot charge a ...